ENTRY       D12265                      Drug
NAME        Mavacamten (JAN/USAN/INN);
            Camzyos (TN)
PRODUCT     CAMZYOS (Myokardia)
FORMULA     C15H19N3O2
EXACT_MASS  273.1477
MOL_WEIGHT  273.3303
CLASS       Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: C01EB24
            Product: D12265<US>
EFFICACY    beta-Cardiac myosin inhibitor
  DISEASE   Hypertrophic cardiomyopathy [DS:H00292]
COMMENT     Treatment of hypertrophic cardiomyopathy
TARGET      MYH7 [HSA:4625] [KO:K17751]
  PATHWAY   hsa04022(4625)  cGMP-PKG signaling pathway
            hsa04260(4625)  Cardiac muscle contraction
            hsa04261(4625)  Adrenergic signaling in cardiomyocytes
            hsa05410(4625)  Hypertrophic cardiomyopathy
METABOLISM  Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576], CYP2C9 [HSA:1559]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01E OTHER CARDIAC PREPARATIONS
                C01EB Other cardiac preparations
                 C01EB24 Mavacamten
                  D12265  Mavacamten (JAN/USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Cardiovascular Agents, Other
               Mavacamten
                D12265  Mavacamten (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               D12265  Mavacamten
              DG01639  CYP2C19 substrate
               D12265  Mavacamten
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D12265  Mavacamten
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Cellular process
               Cytoskeleton
                MYH7
                 D12265  Mavacamten (JAN/USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D12265
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D12265
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D12265
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D12265
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D12265
DBLINKS     CAS: 1642288-47-8
ATOM        20
            1   C8x C     7.2800  -16.6600
            2   C8x C     7.2800  -18.0600
            3   C8x C     8.4924  -18.7600
            4   C8x C     9.7049  -18.0600
            5   C8y C     9.7049  -16.6600
            6   C8x C     8.4924  -15.9600
            7   C1c C    10.9360  -15.9490
            8   N1b N    12.1412  -16.6447
            9   C8y C    13.3235  -15.9619
            10  C8x C    14.5175  -16.6512
            11  C8y C    15.7299  -15.9512
            12  N4y N    15.7299  -14.5512
            13  C8y C    14.5360  -13.8619
            14  N4x N    13.3235  -14.5619
            15  C1c C    16.9534  -13.8446
            16  C1a C    18.1624  -14.5425
            17  C1a C    16.9532  -12.4601
            18  O5x O    14.5359  -12.4602
            19  O5x O    16.9612  -16.6622
            20  C1a C    10.9357  -14.5601
BOND        21
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12   11  12 1
            13   12  13 1
            14   13  14 1
            15    9  14 1
            16   12  15 1
            17   15  16 1
            18   15  17 1
            19   13  18 2
            20   11  19 2
            21    7  20 1 #Down
///
